Our mission is to eliminate inaccuracy and waste when translating drug candidates to clinical trials using AI-driven, multi-disciplinary quantitative methods that predict patient outcomes.
.svg)
.svg)
.svg)
Our service offerings deliver insights for pharmaceutical companies, biotechs, and academic & research institutions. We also partner in risk-sharing collaborations to develop promising drugs.
PulmoSIM Therapeutics, a wholly-owned subsidiary of VeriSIM Life, identifies licensable candidates for preclinical translation and out-licensing to commercialization partners.
.svg)
.png)
Addressing the unmet needs of patients everywhere is our passion. Are you motivated by ownership in your work and a mission to make a difference? Do you embrace diversity? Is continuous learning part of your DNA? This is what drives the team at VeriSIM Life every day. Learn more about our mission and make up.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
